Adrián Puerta (Adrian Puerta)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Topics

Ultra High Performance Liquid Chromatography

Mass Spectrometry

Cancer Stem Cells

Top Venues

Molecules (Basel, Switzerland)

Beilstein journal of organic chemistry

Antioxidants (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Mónica Martínez-Montiel, Laura L Romero-Hernández, Simone Giovannuzzi, Paloma Begines, Adrián Puerta, Ana I Ahuja-Casarín, Miguel X Fernandes, Penélope Merino-Montiel, Sara Montiel-Smith, Alessio Nocentini, José Manuel Padrón, Claudiu T Supuran, José G Fernández-Bolaños, Óscar López
Conformationally Restricted Glycoconjugates Derived from Arylsulfonamides and Coumarins: New Families of Tumour-Associated Carbonic Anhydrase Inhibitors. International journal of molecular sciences 24 (11) (2023)
Adrián J Santiago-Benítez, Adrián Puerta, José Manuel Padrón, Manuel Norte, José Javier Fernández, Antonio Hernández Daranas, Francisco Cen-Pacheco
Antiproliferative effect of natural and semisynthetic polyethers from Laurencia viridis . Natural product research (2023)
Andres Alguacil, Franco Scalambra, Pablo Lorenzo-Luis, Adrián Puerta, Aday González-Bakker, Zenaida Mendoza, José Manuel Padrón, Antonio Romerosa
Tetranuclear Ru 2 Cu 2 and Ru 2 Ni 2 complexes with nanomolar anticancer activity. Dalton transactions (Cambridge, England : 2003) (2023)
Adrián Puerta, Aday González-Bakker, Guido Santos, José Manuel Padrón
Early Pharmacological Profiling of Antiproliferative Compounds by Live Cell Imaging. Molecules (Basel, Switzerland) 27 (16) (2022)
María F Beer, Guillermo F Reta, Adrián Puerta, Augusto E Bivona, Andrés Sánchez Alberti, Natacha Cerny, Emilio L Malchiodi, Carlos E Tonn, José Manuel Padrón, Valeria Patricia Sülsen, Osvaldo J Donadel
Oxonitrogenated Derivatives of Eremophilans and Eudesmans: Antiproliferative and Anti- Trypanosoma cruzi Activity. Molecules (Basel, Switzerland) 27 (10) (2022)
Ruth E Barrientos, Elena Ibáñez, Adrián Puerta, José Manuel Padrón, Adrián Paredes, Fredi Cifuentes, Javier Romero-Parra, Javier Palacios, Jorge Bórquez, Mario Juan Simirgiotis
Phenolic Fingerprinting and Bioactivity Profiling of Extracts and Isolated Compounds from Gypothamnium pinifolium Phil. Antioxidants (Basel, Switzerland) 11 (12) (2022)
Subham G Patel, Aday González-Bakker, Ruturajsinh M Vala, Paras J Patel, Adrián Puerta, Apoorva Malik, Rakesh K Sharma, José Manuel Padrón, Hitendra M Patel
Microwave-assisted multicomponent synthesis of antiproliferative 2,4-dimethoxy-tetrahydropyrimido[4,5- b ]quinolin-6(7 H )-ones. RSC advances 12 (47) (2022)
I Caroline Vaaland, Óscar López, Adrián Puerta, Miguel X Fernandes, José Manuel Padrón, José G Fernández-Bolaños, Magne Olav Sydnes, Emil Lindbäck
Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2022)
Giulia Arrighi, Adrián Puerta, Andrea Petrini, Francisco J Hicke, Alessio Nocentini, Miguel X Fernandes, José Manuel Padrón, Claudiu T Supuran, José G Fernández-Bolaños, Óscar López
Squaramide-Tethered Sulfonamides and Coumarins: Synthesis, Inhibition of Tumor-Associated CAs IX and XII and Docking Simulations. International journal of molecular sciences 23 (14) (2022)
Rodney Lacret, Adrián Puerta, Sebastian Granica, Aday González-Bakker, Danela Hevia, Yiling Teng, Candelaria C Sánchez-Mateo, Pedro Luis Pérez de Paz, José Manuel Padrón
Bioactive Potential: A Pharmacognostic Definition through the Screening of Four Hypericum Species from the Canary Islands. Molecules (Basel, Switzerland) 27 (18) (2022)
Carlos Fernández-Galleguillos, Javier Romero-Parra, Adrián Puerta, José Manuel Padrón, Mario Juan Simirgiotis
Alkaloid Profiling, Anti-Enzymatic and Antiproliferative Activity of the Endemic Chilean Amaryllidaceae Phycella cyrtanthoides . Metabolites 12 (2) (2022)
Dario P Anobile, Mauro Niso, Adrián Puerta, Stephanie M Fraga Rodrigues, Francesca Serena Abatematteo, Soodabeh Shahidsales, Carmen Abate, Chiara Riganti, Elisa Giovannetti
New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. Molecules (Basel, Switzerland) 27 (5) (2022)
Tereza Cristina Santos Evangelista, Óscar López, Adrián Puerta, Miguel X Fernandes, Sabrina Baptista Ferreira, José Manuel Padrón, José G Fernández-Bolaños, Magne Olav Sydnes, Emil Lindbäck
A hybrid of 1-deoxynojirimycin and benzotriazole induces preferential inhibition of butyrylcholinesterase (BuChE) over acetylcholinesterase (AChE). Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Ruth E Barrientos, Elena Ibáñez, Adrián Puerta, José Manuel Padrón, Adrián Paredes, Fredi Cifuentes, Javier Romero-Parra, Javier Palacios, Jorge Bórquez, Mario Juan Simirgiotis
Phenolic Fingerprinting and Bioactivity Profiling of Extracts and Isolated Compounds from Gypothamnium pinifolium Phil. Antioxidants (Basel, Switzerland) 11 (12) (2022)
Giovanna Bosica, Kaylie Demanuele, José Manuel Padrón, Adrián Puerta
Correction: One-pot multicomponent green Hantzsch synthesis of 1,2-dihydropyridine derivatives with antiproliferative activity. Beilstein journal of organic chemistry 17 (2021)
Ruturajsinh M Vala, Mayank G Sharma, Divyang M Patel, Adrián Puerta, José Manuel Padrón, Venkatachalam Ramkumar, Ramesh L Gardas, Hitendra M Patel
Synthesis and in vitro study of antiproliferative benzyloxy dihydropyrimidinones. Archiv der Pharmazie 354 (6) (2021)
Giovanna Bosica, Kaylie Demanuele, José Manuel Padrón, Adrián Puerta
One-pot multicomponent green Hantzsch synthesis of 1,2-dihydropyridine derivatives with antiproliferative activity. Beilstein journal of organic chemistry 16 (2020)
Paloma Begines, Lucía Sevilla-Horrillo, Adrián Puerta, Rebecca Puckett, Samuel Bayort, Irene Lagunes, Inés Maya, José Manuel Padrón, Óscar López, José G Fernández-Bolaños
Masked Phenolic-Selenium Conjugates: Potent and Selective Antiproliferative Agents Overcoming P-gp Resistance. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)